GPT and graft versus host disease: Both methodologies have been implemented using GMP grade standards showing promising results in clinical trials and a beneficial outcome in HSCT patients for improving immune reconstitution without increasing the risk of GvHD (ALT-TEN (15), NCT01656135 (16), and NCT03198234 (17).